Immunological status in three patients, thirty years after living related renal transplantation. Antibody production in long-term survivors

Transplant Immunology

Volumn 18, Issue 4, 2008, Pages 368-372

  Miyamoto, Naoshi ^a   Ishida, Hideki ^a   Furusawa, Miyuki ^a   Shimizu, Tomokazu ^a   Shirakawa, Hiroki ^a   Omoto, Kazuya ^a   Tanabe, Kazunari ^a   Toma, Hiroshi ^b  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b Ushiku Aiwa General Hospital   (Japan)

Author keywords

Anti HLA antibody; Antibody production; Renal transplantation

Indexed keywords

HLA ANTIBODY; HLA ANTIGEN; MINOR HISTOCOMPATIBILITY ANTIGEN;

ADULT; ANTIBODY PRODUCTION; ARTICLE; CASE REPORT; FEMALE; HLA MATCHING; HUMAN; IMMUNE STATUS; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; LIVING DONOR; LONG TERM CARE; MALE; PRIORITY JOURNAL; PROTEINURIA;

ADULT; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; ISOANTIBODIES; KIDNEY TRANSPLANTATION; LIVING DONORS; MALE; MIDDLE AGED; SURVIVORS;

EID: 37349101631     PISSN: 09663274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trim.2007.10.008     Document Type: Article

References (15)

1. Mauiyyedi S., Pelle P.D., Saidman S., et al. Chronic humoral rejection: identification of antibody-mediated chronic renal allograft rejection by C4d deposits in peritubular capillaries. J Am Soc Nephrol 12 (2001) 574-582
2. Mauiyyedi S., Crespo M., Collins A.B., et al. Acute humoral rejection in kidney transplantation: morphology, immunopathology, and pathologic classification. J Am Soc Nephrol 13 (2002) 779-787
3. Montgomery R.A., Zachary A.A., Racusen L.C., et al. Plasmapheresis and intravenous immune globulin provides effective rescue therapy for refractory humoral rejection and allows kidneys to be successfully transplanted into cross-match positive recipients. Transplantation 70 (2000) 887-895
4. Halloran P.F., Schlaut J., Solez K., et al. The significance of the class 1 response. Clinical and pathologic features of renal transplants with anti-class 1 like antibody. Transplantation 53 (1992) 550-555
5. Theruvath T.P., Saidman S.L., Mauiyyedi S., et al. Control of antidonor antibody production with tacrolimus and mycophenolate mofetil in renal allograft recipients with chronic rejection. Transplantation 72 (2001) 77-83
6. Olerup O., and Zetterquist H. HLA-DRB01 subtyping by allele-specific PCR amplification; a sensitive specific and rapid technique. Tissue Antigens 37 (1991) 197-204
7. Bray R.A., Lebeck L.K., and Gebel H.M. The flow cytometric crossmatch; dual colour analysis of T cell and B cell reactivities. Transplantation 48 (1989) 834-840
8. Gloor J.M., DeGoey S., Ploeger N., et al. Persistence of low levels of alloantibody after desensitization in crossmatch positive living donor kidney transplantation. Transplantation 78 (2003) 221
9. Ishida H., Kawai T., Tanabe K., et al. Status of microchimerism in recipients 15 years after living related kidney transplantation. Transplantation 62 (1996) 126-128
10. Terasaki P. Humoral theory of transplantation. Am J Transplant 3 (2003) 665-673
11. Pei R., Lee J.H., Shih N.J., et al. Single human leukocyte antigen flow cytometry beads for accurate identification of human leukocyte antigen antibody specificities. Transplantation 75 (2003) 43-49
12. Halloran P.F. The clinical importance of alloantibody-mediated rejection. Am J Transplant 3 (2003) 639-640
13. Mathew J.M., Joyce S., Lawrence W., et al. Evidence that antibodies eluted from rejected kidneys of HLA-identical transplants define a non-MHC alloantigen expressed on human kidneys. Transplantation 52 (1991) 559-562
14. Starzl T.E., Demetris A.J., Murase N., et al. Cell migration, chimerism, and graft acceptance. Lancet 339 (1992) 1579
15. Weinstein D., Braun W.E., Cook D., et al. Ultra-late antibody mediated rejection 30 years after a living related renal allograft. Am J Transplant 5 (2005) 2576-2581